Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

TSE:7380
TSE:7380Banks

Juroku Financial GroupInc (TSE:7380) EPS Momentum Challenges Cautious Credit Narrative

Juroku Financial GroupInc (TSE:7380) reported Q3 2026 revenue of ¥32,576 million and basic EPS of ¥187.61, with net income of ¥6,705 million. Over the trailing twelve months, revenue came in at ¥138,445 million and EPS was ¥652.99. Over recent quarters the company has seen revenue move between ¥28,920 million in Q2 2025 and ¥37,379 million in Q4 2025, alongside quarterly EPS ranging from ¥113.45 to ¥187.61. This places the latest results within a steadily building earnings profile. With a...
NasdaqGS:CSX
NasdaqGS:CSXTransportation

Is It Time To Reassess CSX (CSX) After Its Recent Share Price Strength?

If you are looking at CSX and wondering whether the current share price offers good value, the key question is how that price compares with what the business might reasonably be worth. CSX shares last closed at US$37.87, with returns of 5.8% over the past week, 4.0% over the past month, 4.4% year to date, 17.1% over 1 year, 21.2% over 3 years and 37.4% over 5 years, which puts recent moves in the context of a longer track record. Recent market attention on CSX has been shaped by ongoing...
NYSE:VZ
NYSE:VZTelecom

How Investors Are Reacting To Verizon Communications (VZ) Earnings Beat, Frontier Deal And 2026 Outlook

Verizon Communications has reported fourth-quarter 2025 results, with revenue rising to US$36,381 million from US$35,681 million a year earlier, while net income fell to US$2,342 million and earnings per share more than halved. Alongside closing its Frontier fiber acquisition, Verizon issued 2026 guidance calling for modest mobility and broadband service revenue growth as it pursues volume-based expansion and cost savings. Next, we’ll examine how Verizon’s earnings beat and higher 2026...
NYSE:BABA
NYSE:BABAMultiline Retail

How Investors Are Reacting To Alibaba Group Holding (BABA) Gaining Access To Nvidia H200 AI Chips

In late January 2026, Chinese regulators cleared Alibaba and other major tech firms to purchase Nvidia’s advanced H200 AI chips, coinciding with Alibaba’s rollout of upgraded Qwen AI models and deeper integration of AI services across its cloud, e-commerce, logistics, and healthcare platforms. This combination of improved access to high-end AI hardware and rapidly expanding in-house AI capabilities underscores Alibaba’s push to position its ecosystem as a full-stack AI infrastructure and...
TSE:8699
TSE:8699Capital Markets

HS Holdings (TSE:8699) Margin Compression To 27.4% Tests Bullish Narratives

HS Holdings (TSE:8699) has reported Q3 2026 revenue of ¥16,194 million and net income excluding extraordinary items of ¥3,883 million, with basic EPS at ¥129.02, alongside trailing 12 month earnings growth of 15.5% and a net profit margin of 27.4%. Over recent quarters, revenue has moved from ¥9,382 million in Q4 2025 to ¥9,622 million in Q1 2026, ¥15,507 million in Q2 2026 and now ¥16,194 million in Q3, while quarterly EPS has ranged between ¥92.67 and ¥130.08 across this period. For...
NasdaqGS:GTX
NasdaqGS:GTXAuto Components

A Look At Garrett Motion (GTX) Valuation After Renewed Ferrari Formula 1 Turbo Partnership

Garrett Motion (GTX) shares are in focus after the company renewed its long-running technical partnership with Scuderia Ferrari HP to supply next generation turbo systems for Ferrari’s 2026 Formula 1 hybrid power unit. See our latest analysis for Garrett Motion. The renewed Ferrari partnership lands at a time when the share price has gained 7.73% over the past 90 days and 3.75% over the last month, while the 1 year total shareholder return of 89.07% and 3 year total shareholder return of...
TSE:4519
TSE:4519Pharmaceuticals

Assessing Chugai Pharmaceutical (TSE:4519) Valuation After Special Dividend And Higher Regular Payout

Chugai Pharmaceutical (TSE:4519) moved into focus after its board approved proposals for a special year end dividend and higher regular dividends, tying these plans to sustained growth in core net income. See our latest analysis for Chugai Pharmaceutical. The special and higher regular dividends come after a strong run in the shares, with a 90 day share price return of 24.85% and a 1 year total shareholder return of 35.25%. The 3 year total shareholder return is very large at around 18x,...
TSE:6702
TSE:6702IT

Fujitsu (TSE:6702) Q3 EPS Strength Challenges Bearish Earnings Decline Narrative

Fujitsu (TSE:6702) has posted Q3 2026 revenue of ¥884.6 billion and basic EPS of ¥46.39, setting the tone for its latest set of numbers. The company has seen quarterly revenue move from ¥924.8 billion in Q3 2025 to ¥884.6 billion in Q3 2026, while basic EPS shifted from ¥28.95 to ¥46.39 over the same period. This gives investors a clear view of how sales and per share earnings are tracking ahead of the full year. With trailing 12 month net profit margins sitting at 8.8%, slightly higher than...
TSE:8628
TSE:8628Capital Markets

Matsui Securities (TSE:8628) Q3 EPS Surge Tests Justification For Premium P/E Multiple

Matsui Securities (TSE:8628) just posted its Q3 2026 scorecard, reporting revenue of ¥12,631 million and basic EPS of ¥17.60, with trailing twelve month revenue at ¥43,764 million and EPS at ¥50.84 providing the backdrop for the latest quarter. The company has seen revenue move from ¥8,961 million and EPS of ¥9.25 in Q3 2025 to ¥12,631 million and EPS of ¥17.60 in Q3 2026. This has occurred alongside trailing twelve month EPS increasing from ¥38.06 in 2024 Q4 to ¥50.84 in 2026 Q3, which puts...
CPSE:NOVO B
CPSE:NOVO BPharmaceuticals

Novo Nordisk’s Diabetes Cell Therapy Push And What It Means For Valuation

Novo Nordisk (CPSE:NOVO B) and Aspect Biosystems are moving into a new phase of their collaboration to develop advanced cellular medicines for diabetes. The partners are working on cell-based therapies that target disease modification or potentially curative treatment options. The program focuses on islet replacement therapy for type 1 diabetes that is designed to function without chronic immune suppression. For readers who mostly associate Novo Nordisk with obesity treatments like Wegovy,...
OM:TREL B
OM:TREL BMachinery

Trelleborg (OM:TREL B) Margin Slip To 10.5% Tests Bullish Profitability Narrative

Trelleborg (OM:TREL B) has wrapped up FY 2025 with Q4 revenue of about SEK8.4b and basic EPS of SEK3.70, set against trailing twelve month revenue of roughly SEK34.3b and EPS of SEK15.76 that frame how the recent quarter fits into the broader year. Over the past few quarters, revenue has moved from SEK8.9b in Q1 2025 to SEK8.4b in Q4 2025, while quarterly EPS ranged from SEK4.08 in Q1 to SEK3.70 in Q4. This gives investors a clearer view of how top line and per share earnings have paired up...
TSE:6345
TSE:6345Machinery

Aichi (TSE:6345) Margin Improvement Supports Bullish Narratives Despite Softer Q3 Revenue

Aichi (TSE:6345) has just posted its Q3 2026 scorecard, reporting revenue of ¥13.6b and basic EPS of ¥22.67, while the trailing twelve months show revenue of ¥56.1b and EPS of ¥88.77 anchored by net income of ¥6.1b. The company has seen revenue move between ¥13.3b and ¥17.9b over the last reported six quarters, with quarterly EPS ranging from ¥4.44 to ¥34.43. This provides a clearer view of how earnings and sales have been tracking into this latest report as margins hold a steady line for...
BME:BBVA
BME:BBVABanks

Is It Too Late To Consider BBVA (BME:BBVA) After Its 7x Five Year Surge?

If you are wondering whether Banco Bilbao Vizcaya Argentaria is attractively priced after a strong run, this article will walk through what the current share price might be implying about its value. The stock last closed at €21.45, with stated returns of 1.8% over 7 days, 7.0% over 30 days, 5.3% year to date and 103.3% over 1 year, plus a very large 3 year return and a more than 7x 5 year return. This naturally raises questions about how much upside or risk is now priced in. Recent coverage...
TSE:1934
TSE:1934Construction

Yurtec (TSE:1934) Margin Gain And EPS Surge Reinforce Bullish Profitability Narratives

Yurtec (TSE:1934) has reported a solid Q3 2026 scorecard, with revenue of about ¥65.6b and basic EPS of ¥68.91, set against a trailing twelve month EPS of ¥191.14 and net income of ¥13.1b. The company’s quarterly revenue moved from ¥70.8b in Q3 2025 to ¥65.6b in Q3 2026, while basic EPS over the same quarters went from ¥55.84 to ¥68.91. This sets up a story where margin trends and earnings efficiency may matter more than top line shifts for investors watching this latest result. See our full...
OM:NCC B
OM:NCC BConstruction

How a Major Danish District Heating Win At NCC (OM:NCC B) Has Changed Its Investment Story

Vestforbraending has selected NCC as turnkey contractor for a major expansion of the district heating network in Herlev near Copenhagen, a past award worth about SEK 700,000,000 that includes civil engineering works and the installation of roughly 46 kilometers of distribution pipes. This contract, part of Denmark’s “Varmeplan 2030” program to extend district heating to tens of thousands of households, adds a sizeable, multi‑year infrastructure project to NCC’s order book. We’ll now...
TSE:7191
TSE:7191Diversified Financial

Entrust (TSE:7191) Margin Gain And EPS Strength Test Bullish Growth Narratives

Entrust (TSE:7191) has put up another busy quarter, with Q3 2026 revenue at ¥3,006 million and basic EPS of ¥16.76, while investors continue to weigh those fresh numbers against the company’s strong 12 month track record of EPS at ¥73.65 and net income of ¥1,647.85 million on revenue of ¥11,685.37 million. The company has seen revenue progress from ¥2,690.52 million in Q3 2025 to ¥3,006 million in Q3 2026, alongside quarterly EPS moving from ¥13.76 to ¥16.76. This gives a clearer view of how...
TSE:8113
TSE:8113Household Products

How a Greener Diaper Boom Could Shape Unicharm’s (TSE:8113) Long-Term Investment Narrative

Recent industry research has highlighted that, looking ahead from today, the global diaper market is projected to expand substantially between 2025 and 2033, supported by rising birth rates in emerging markets, greater incontinence care needs, urbanization, and higher disposable incomes. An important insight from this outlook is the growing emphasis on sustainable, eco-friendly diaper innovations, which could increasingly shape consumer preferences and competitive positioning for producers...
NasdaqGS:WDC
NasdaqGS:WDCTech

Why Western Digital (WDC) Is Up 14.4% After AI-Fueled Earnings Beat And New Dividend Announcement

Western Digital reported past fiscal second-quarter 2026 results with revenue of US$3,017 million and net income of US$1,842 million, alongside a new quarterly dividend of US$0.125 per share and guidance for third-quarter revenue of US$3,200 million. The earnings surge was closely tied to AI-related demand, as hyperscalers increasingly relied on Western Digital’s high-capacity hard drives and flash storage to power data-heavy AI workloads. Next, we’ll examine how AI-driven demand for...
NSE:6623
NSE:6623Electrical

Aichi Electric (NSE:6623) Margin Improvement Reinforces Bullish Profitability Narrative

Aichi Electric (NSE:6623) has put up a clean set of numbers for Q3 2026, with revenue of ¥32.6 billion and basic EPS of ¥254.28 as investors weigh these results against a year of improving profitability. The company has seen quarterly revenue move from ¥29.6 billion in Q3 2025 to ¥32.6 billion in Q3 2026, while basic EPS stepped up from ¥190.84 to ¥254.28 over the same period, and trailing twelve month EPS reached ¥851.63 alongside a net margin of 6.4% versus 5.6% a year earlier. Overall, the...
TSX:GSY
TSX:GSYConsumer Finance

Assessing Goeasy (TSX:GSY) Valuation After Strong Growth, Earnings And Dividend Track Record

Recent attention on goeasy (TSX:GSY) centers on its loan book growth, earnings profile, and regular dividends, along with ongoing risks tied to regulation, interest rates, and credit quality that matter for anyone considering the lender today. See our latest analysis for goeasy. At a share price of CA$125.46, goeasy has seen a 90 day share price return decline of 25.61% and a 1 year total shareholder return decline of 29.22%. Longer term 3 and 5 year total shareholder returns of 5.84% and...
TSE:4502
TSE:4502Pharmaceuticals

Takeda Pharmaceutical (TSE:4502) Margin Compression To 2.5% Reinforces Bearish Profitability Narratives

Takeda Pharmaceutical (TSE:4502) has posted Q3 2026 revenue of ¥1.19t and basic EPS of ¥65.65, with trailing twelve month EPS at ¥71.70 and net income of ¥112.93b giving investors a fresh read on profitability after a period that included a large one off loss of ¥143.7b. The company has seen quarterly revenue move between ¥1.06t in Q4 2025 and ¥1.19t in Q3 2026. Basic EPS has swung from a loss of ¥65.22 per share in Q4 2025 to ¥79.40 in Q1, a small loss of ¥7.48 in Q2 and the latest ¥65.65 in...